Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New drug combo aims to fight tough lung cancer
Disease control Recruiting nowThis phase II trial is testing whether combining the chemotherapy drug temozolomide with the immunotherapy atezolizumab can help shrink tumors or slow the disease in people with advanced small cell lung cancer that has spread or returned. About 56 participants will receive the co…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 23, 2026 20:32 UTC
-
New combo therapy targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis early-stage trial tests the safety and best dose of two drugs—vismodegib and atezolizumab—given together to people with advanced non-small cell lung cancer that has returned or spread. Vismodegib blocks certain enzymes that help cancer grow, while atezolizumab boosts the imm…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 17, 2026 12:10 UTC
-
New hope for advanced lung cancer: drug combo trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug (PBF-1129) combined with an immunotherapy (nivolumab) in 30 adults with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand side effects. Participants must have already tr…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC